People Who Use Drugs (PWUD) are at high risk of non-fatal overdose and other drug-related harms. The United Kingdom drugs policy landscape makes it challenging to support those at risk. Tays...
New research presented at IAS 2023 included an 88% reduction in new HIV infections in Sydney, practice-changing results from the REPRIEVE trial, and more. Healthcare stigma has a ...
New research presented at IAS 2023 included an 88% reduction in new HIV infections in Sydney, practice-changing results from the REPRIEVE trial, and more. Despite a high prevalenc...
New research presented at IAS 2023 included an 88% reduction in new HIV infections in Sydney, practice-changing results from the REPRIEVE trial, and more. Despite a reduction in...
New research presented at IAS 2023 included an 88% reduction in new HIV infections in Sydney, practice-changing results from the REPRIEVE trial, and more. HIV-related cardiovascul...
New research presented at IAS 2023 included an 88% reduction in new HIV infections in Sydney, practice-changing results from the REPRIEVE trial, and more. Following news that Inne...
Self-assessment of cognitive abilities can be an important predictor of clinical outcomes. This study examined impairments in self-assessments of cognitive performance, assessed with traditi...
HIV-associated neurocognitive disorders (HAND) are the result of the activity of HIV-1 within the central nervous system (CNS). While the introduction of antiretroviral therapy (ART) has sig...
Despite HCV cure, individuals with HIV and prior HCV infection remained at higher risk for mortality than those with HIV alone, especially 12 months after cure. “Direct-acting antiv...
An 83-year-old man presented with visual disturbance and right hemiparalysis, one month after daratumumab, bortezomib, and dexamethasone administration for multiple myeloma (MM). Blood scree...
![[A case of progressive multifocal leukoencephalopathy associated with daratumumab, bortezomib, and dexamethasone for multiple myeloma].](https://www.physiciansweekly.com/wp-content/uploads/2018/05/e662e8c6-bacteria-infection.png)
Varicella-Zoster virus (VZV) vasculopathy occasionally occurs in immunocompromised patients and is difficult to treat. The risk factor and optimal therapy remain unclear. Patients with human...
Sex-positive HIV prevention that moves beyond perceptions of risk may improve PrEP uptake among young adults who identify as sexual/gender minorities of color. “There are so many in...
To analyze the surgical efficacy of patients with mixed hearing loss and otosclerosis with different air bone gap (ABG) before surgery, and to provide reference for the prognosis evaluation...
The subcutaneous (H-SC) formulation of trastuzumab was demonstrated to be as effective and safe as intravenous (H-IV) and highly preferred by patients in early breast cancer. The present ran...
The background of this paper starts with the history and significance of the author's relationship to the Campaign, U=U; Undetectable equals Untransmissable as an Indigenous woman and well-k...
We analysed the impact of increased antiretroviral therapy (ART) on HIV epidemiology and healthcare costs in Australia during the 'Treatment-as-prevention' and 'Undetectable equals Untransmi...
Improving the reliability of handoffs and care transitions is an important goal for many health care organizations. Increasing evidence shows that human-centered design and improved teamwork...
Socioeconomic factors, such as housing, and personal identity, such as sexual orientation, jointly influence durable viral suppression in HIV. “We know that viral suppression rates...
Incorporating HPV vaccination into PrEP services may increase the number of patients who receive the vaccine and improve anal cancer prevention efforts. “HPV vaccination is th...
Bacteria colonizing the nasopharynx play a key role as gatekeepers of respiratory health. Yet, dynamics of early life nasopharyngeal (NP) bacterial profiles remain understudied in low- and m...
The latest articles and insights from your colleagues in your specialty(ies) of choice.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
